(210 ILCS 4/1)

Sec. 1.

Short title.

This Act may be cited as the

Alzheimer's Special Care Disclosure Act.

(Source: P.A. 90‑341, eff. 1‑1‑98.)

(210 ILCS 4/10)

Sec. 10.

Facility defined.

As used in this Act, "facility" means a facility licensed or permitted under the Nursing Home Care Act, the Life Care Facility Act, the Assisted Living and Shared Housing Act, the Community Living Facilities Licensing Act, or subsection (a‑20) of Section 30 of the Alternative Health Care Delivery Act.

(Source: P.A. 90‑341, eff. 1‑1‑98; 91‑656, eff. 1‑1‑01; 91‑838, eff. 6‑16‑00.)

(210 ILCS 4/15)

Sec. 15.

Disclosure requirements.

A facility that offers to provide care for persons with Alzheimer's disease through an Alzheimer's special care unit or center shall disclose to a State agency responsible for licensing or permitting the facility or to a potential or actual client of the facility the following information in writing on request of the Agency or client:

(1) the form of care or treatment that distinguishes

the facility as suitable for persons with Alzheimer's disease;

(2) the philosophy of the facility concerning the

care or treatment of persons with Alzheimer's disease;

(3) the facility's pre‑admission, admission, and

discharge procedures;

(4) the facility's assessment, care planning, and

implementation guidelines in the care and treatment of persons with Alzheimer's disease;

(5) the facility's minimum and maximum staffing

ratios, specifying the general licensed health care provider to client ratio and the trainee health care provider to client ratio;

(6) the facility's physical environment;

(7) activities available to clients at the facility;

(8) the role of family members in the care of

clients at the facility; and

(9) the costs of care and treatment under the

program or at the center.

(Source: P.A. 90‑341, eff. 1‑1‑98.)

(210 ILCS 4/20)

Sec. 20.

A facility that offers to provide care for persons with Alzheimer's disease through an Alzheimer's special care unit or center shall, within 180 days of the effective date of this Act, provide to the State agency responsible for licensing or permitting the facility the disclosure document prepared by a facility in accordance with Section 15. The State agency shall review the document for accuracy as part of the license or permit renewal requirements under the appropriate Act.

(Source: P.A. 90‑341, eff. 1‑1‑98.)

(210 ILCS 4/25)

Sec. 25.

Penalties.

A facility that violates a provision of this Act shall be guilty of a business offense, subject to a fine not to exceed $500 for a first offense and a fine not to exceed $1,000 for a second or subsequent offense.

(Source: P.A. 90‑341, eff. 1‑1‑98.)

(210 ILCS 4/5)

Sec. 5.

Legislative purpose.

This Body finds it to be in the public interest to promote the highest standard of medical care currently available to people suffering from Alzheimer's disease without restricting the future implementation of treatment options that may become available through ongoing research. It is further in the public interest to protect consumers from false claims of specialized care of Alzheimer's disease. Therefore, the General Assembly declares it to be the purpose of this Act to require health care facilities offering specialized care in the treatment of Alzheimer's disease to fully inform the public regarding the facility and program of care.

(Source: P.A. 90‑341, eff. 1‑1‑98.)

(210 ILCS 4/60)

Sec. 60.

(Amendatory provisions; text omitted).

(Source: P.A. 90‑341, eff. 1‑1‑98; text omitted.)

(210 ILCS 4/65)

Sec. 65.

(Amendatory provisions; text omitted).

(Source: P.A. 90‑341, eff. 1‑1‑98; text omitted.)

(210 ILCS 4/70)

Sec. 70.

(Amendatory provisions; text omitted).

(Source: P.A. 90‑341, eff. 1‑1‑98; text omitted.)